These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3992326)

  • 1. [Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
    Ruksin VV
    Sov Med; 1985; (2):54-6. PubMed ID: 3992326
    [No Abstract]   [Full Text] [Related]  

  • 2. Current indications for vasodilator therapy for left ventricular failure.
    Franciosa JA
    Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L; Higa SS
    Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent progress in the treatment of cardiac insufficiency. Contribution of vasodilator agents].
    Ivanciuc I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):385-92. PubMed ID: 44561
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of captopril in the treatment of circulatory insufficiency in the acute period of myocardial infarction].
    Pinzur SV; Belousov IuB
    Sov Med; 1991; (9):41-3. PubMed ID: 1798922
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
    Verma SP; Silke B; Reynolds GW; Kelly JG; Richmond A; Taylor SH
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):274-81. PubMed ID: 1381019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC; Robinson PH
    Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment].
    González-Juanatey JR; Amaro Cendón A; Vega Fernández M; Gil de la Peña M
    Med Clin (Barc); 1988 Jan; 90(3):93-6. PubMed ID: 3280894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of the effectiveness of using peripheral vasodilators in the treatment of patients with acute myocardial infarction complicated by left-ventricular failure].
    Uchaĭkina LV; Zolotareva NIu; Vakhliaev VD; Smirnova IE
    Kardiologiia; 1991 Dec; 31(12):15-8. PubMed ID: 1816434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of peripheral vasodilators in the treatment of cardiac insufficiency in the acute period of myocardial infarction in elderly patients].
    Ruksin VV
    Vrach Delo; 1987 Oct; (10):26-9. PubMed ID: 3424726
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of cardiac failure with vasodilators (author's transl)].
    Imhof P
    Schweiz Rundsch Med Prax; 1978 May; 67(22):219-29. PubMed ID: 418395
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of nitrates in acute therapy of heart failure with and without lung edema].
    Beck OA
    Z Kardiol; 1985; 74 Suppl 1():15-22. PubMed ID: 3922141
    [No Abstract]   [Full Text] [Related]  

  • 14. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
    Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI1-4. PubMed ID: 8500232
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemodynamic effects of intravenous isosorbide dinitrate in patients of cardiac failure following acute myocardial infarction.
    Pande AK; Ambardekar SS; Kumar A; Tulpule AT; Goyal BK
    Indian Heart J; 1985; 37(6):339-42. PubMed ID: 3836934
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure.
    Gori T; Münzel T
    Clin Res Cardiol; 2009 Oct; 98(10):677-9. PubMed ID: 19644645
    [No Abstract]   [Full Text] [Related]  

  • 17. [What is the value of organic nitrate preparations in treatment of chronic heart failure?].
    Internist (Berl); 1996 Jul; 37(7):739. PubMed ID: 8830005
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vasodilator therapy of pump failure in acute myocardial infarction].
    Trongé J; Villamayor RM; Pérez Baliño N; Riccitelli MA; Bertolasi CA; Bertolasi CA
    Cardiology; 1980; 66 Suppl 2():154-61. PubMed ID: 7285026
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic and isotope study of the effects of sublingual and oral administration of isosorbide dinitrate in cardiac insufficiency].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(3):361-77. PubMed ID: 791567
    [No Abstract]   [Full Text] [Related]  

  • 20. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Chow AY
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15761997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.